Bone growth stimulators are mainly used to facilitate bone growth in impaired or delayed healing fractures/fusions. Bone growth stimulators apply electrical or ultrasound waves to the site of the fracture/fusion.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Bone Growth Stimulators under development
 - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
 - The report reviews the major players involved in the development of Bone Growth Stimulators and list all their pipeline projects
 - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
 - The report provides key clinical trial data of ongoing trials specific to pipeline products
 - Recent developments in the segment / industry
 
Reasons to Buy
The report enables you to :
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
 - Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
 - Identify and understand important and diverse types of Bone Growth Stimulators under development
 - Develop market-entry and market expansion strategies
 - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
 - In-depth analysis of the product’s current stage of development, territory and estimated launch date
 
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bionext Biotech Products Ltd.
 - Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
 - Collamedix Inc
 - Curative Biosciences, Inc.
 - DJO Global Inc
 - Eepta Pty Ltd
 - GreenBone Ortho srl
 - Industrie Biomediche Insubri SA
 - Inion Oy
 - Johns Hopkins University
 - KeraCure, Inc. (Inactive)
 - Lattice Biologics Ltd
 - Magle Chemoswed AB
 - Max Biopharma Inc
 - NC Biomatrix BV
 - NDSU Research Foundation
 - Oklahoma State University
 - Oligo Medic Inc
 - Orthocell Ltd
 - Orthofix Medical Inc
 - OsteoGenix Incorporated (Inactive)
 - REGENECURE Ltd
 - Texas A&M University
 - The University of Nottingham
 - Universiti Putra Malaysia
 - University of California Davis
 - University of Florida
 - University of Wisconsin Madison
 - Wright Medical Group NV (Inactive)
 - ZetaGen Therapeutics Inc
 

